Chelsea Davies, 31, started getting abdominal pain and constipation in May 2021, but doctors put it down to period pain. Despite her concerns it could be cancer, she was told she was "too young" and ...

The DUO-O trial showed significant improvement in progression-free survival with Imfinzi, Avastin, and Lynparza, but no significant overall survival benefit. The study was a double-blind, multicenter ...

GREENSBORO, N.C. — Nearly 20,000 women in our country will end up with ovarian cancer this year, according to the American Cancer Society. Cone Health doctors say knowing your risk factors is ...

BERLIN — The combination of pembrolizumab with weekly paclitaxel, with or without bevacizumab, leads to significant improvements in survival outcomes in patients with platinum-resistant recurrent ...

On a warm day seven years ago, I was walking home from my coworking space in New York City when all of a sudden I was overcome with chills. I had been feeling totally fine until that moment, but the ...

Please provide your email address to receive an email when new articles are posted on . Women who had minimal residual disease following first-line ovarian cancer treatment had significantly worse OS.